2024 Annual Conference on Vaccinology Research (ACVR)

Registration Now Closed

Registration is now closed for the 2024 Annual Conference on Vaccinology Research: Preparing for the Future.

The conference will take place online on May 8-10, 2024, as we convene leading experts, researchers, and professionals to explore the latest advancements in vaccine research for this unparalleled opportunity to network, learn, and contribute to the future of vaccine development.

Follow the conference on social media using #ACVR for the latest updates on speakers and sessions.

About the Conference

The Annual Conference on Vaccinology Research brings together the diverse disciplines involved in vaccine research, development, implementation, and real-world evaluation. By drawing upon an international audience of scientists and researchers, healthcare professionals, manufacturers, and public health officials, the conference is designed to facilitate the exchange of ideas across a broad range of disciplines, addressing challenges and breakthroughs in vaccinology.

For more than 25 years, the annual conference has been well-regarded by attendees as a forum for relevant discussions and collaborations across the breadth of vaccinology.

Questions? Email: vaccine@nfid.org

Speakers

The 2024 program features an array of well-known experts bringing unique insights and expertise to the forefront of vaccine development. From leading researchers and clinicians to industry pioneers and public health advocates, the lineup of speakers will inspire and inform attendees. Join us for the opportunity to engage with these thought leaders as they share their perspectives on advancing vaccine science and preparing for the future.

Continuing Education and Learning Objectives

Overall Conference Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Discuss recent scientific advances contributing to vaccine research, development, implementation, and real-world evaluation
  • Identify novel research opportunities and scientific challenges associated with vaccine development, implementation, and real-world evaluation
  • Evaluate the role of vaccines in preventing and mitigating existing, emerging, and re-emerging infectious diseases
ACVR Posters

Planning Committee

Kimberley Fox, MD, MPH

Kimberley Fox, MD, MPH

Bruce G. Gellin, MD, MPH

Portrait of Hana Golding

Hana Golding, PhD

Robert H. Hopkins, Jr., MD

Robert H. Hopkins, Jr., MD

Nicole Klein Portrait

Nicole P. Klein, MD, PhD

Flor M. Muñoz, MD, MSc

Seema U. Nayak, MD

Kathleen M. Neuzil, MD, MPH